CCN2 and acute lymphoblastic leukemia: A phase II study was conducted on the effectiveness of clofarabine and cytarabine in adults with relapsed/refractory ALL while also examining whether connective tissue growth factor (CTGF) and nucleoside transporter expression affect the response to these therapies.